TP53 and cancer: This sample harbored a TP53G187S mutation, which has been shown to be a recurrent TP53 alteration across cancers.21 Alterations in p53 have not been found to be significantly recurrent in meningioma, but this alteration may explain the significant rates of disruption found in this sample.